These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 92687)

  • 1. Congenital abnormalities.
    Scrimgeour JB; Cockburn F
    Lancet; 1979 Dec 22-29; 2(8156-8157):1349-52. PubMed ID: 92687
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
    Haddow JE
    Semin Perinatol; 1990 Dec; 14(6):488-503. PubMed ID: 1706536
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum analysis in pregnant women. Mass screening is an effective way to discover chromosome aberrations--arguments for and against].
    Kristoffersson U; Nørgaard-Pedersen B
    Lakartidningen; 1995 Mar; 92(12):1205-6, 1211-2. PubMed ID: 7535873
    [No Abstract]   [Full Text] [Related]  

  • 5. A report of the safety and accuracy of midtrimester amniocentesis at the Medical College of Georgia: eight and one half years' experience.
    Manganiello PD; Byrd JR; Tho PT; McDonough PG
    Am J Obstet Gynecol; 1979 Aug; 134(8):911-6. PubMed ID: 157073
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possibilities of genetic counseling for prenatal diagnosis in pediatric practice].
    Murken JD; Stengel-Rutkowski S; Zahn V; Jensen M
    Fortschr Med; 1979 Sep; 97(34):1443-7. PubMed ID: 159245
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of the origin of birth defects in pregnant women from the Kujawy-Pomerania Region.
    Lauda-Świeciak A; Bednarek S; Skórczewski J; Borowski D; Dubiel M
    Ginekol Pol; 2016; 87(10):711-716. PubMed ID: 27958624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
    Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
    Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence risk after neural tube defects in a genetic counselling clinic.
    Czeizel A; Métneki J
    J Med Genet; 1984 Dec; 21(6):413-6. PubMed ID: 6512828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal screening for genetic disorders: Suggested guidelines for the Indian Scenario.
    Phadke SR; Puri RD; Ranganath P
    Indian J Med Res; 2017 Dec; 146(6):689-699. PubMed ID: 29664026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal genetic screening for Down syndrome and open neural tube defects using maternal serum markers in Thai pregnant women.
    Wasant P; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():244-8. PubMed ID: 15906746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down's syndrome and neural tube defects in the same families.
    Olsen JH; Winther JF
    Lancet; 2003 Apr; 361(9366):1316. PubMed ID: 12711462
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening and diagnosis of fetal neural tube defects, abdominal wall defects and Down's syndrome. With special reference to biochemical and ultrasound screening in the second trimester of pregnancy and to early amniocentesis.
    Jørgensen FS
    Dan Med Bull; 2001 Aug; 48(3):127-45. PubMed ID: 11556264
    [No Abstract]   [Full Text] [Related]  

  • 14. Maternal serum screening of Palestinian women in the West Bank.
    Husseini A; Akkawi M
    East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates of maternal age-specific risks of Down-syndrome birth in women aged 34-41.
    Hook EB
    Lancet; 1976 Jul; 2(7975):33-4. PubMed ID: 59087
    [No Abstract]   [Full Text] [Related]  

  • 16. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical screening.
    Cuckle HS; Wald NJ
    Curr Opin Obstet Gynecol; 1990 Apr; 2(2):246-52. PubMed ID: 1714781
    [No Abstract]   [Full Text] [Related]  

  • 18. [Genetic counseling and prenatal diagnosis in Down's syndrome].
    Papp Z
    Orv Hetil; 1974 May; 115(19):1103-6. PubMed ID: 4274931
    [No Abstract]   [Full Text] [Related]  

  • 19. New uncertainties in prenatal screening for neural tube defect.
    Harris R; Read AP
    Br Med J (Clin Res Ed); 1981 May; 282(6274):1416-8. PubMed ID: 6164431
    [No Abstract]   [Full Text] [Related]  

  • 20. Maternal age-specific costs of detecting Down syndrome and neural tube defects.
    Sadovnick AD; Baird PA
    Can J Public Health; 1982; 73(4):248-50. PubMed ID: 6215977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.